Turpeinen U - Search Results

1

Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder.

Haataja L, Parkkola R, Sonninen P, Vanhanen SL, Schleutker J, Aärimaa T, Turpeinen U, Renlund M, Aula P. Haataja L, et al. Among authors: turpeinen u. Neuropediatrics. 1994 Oct;25(5):238-44. doi: 10.1055/s-2008-1073028. Neuropediatrics. 1994. PMID: 7885532

2

CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis.

Riikonen R, Vanhanen SL, Tyynelä J, Santavuori P, Turpeinen U. Riikonen R, et al. Among authors: turpeinen u. Neurology. 2000 May 9;54(9):1828-32. doi: 10.1212/wnl.54.9.1828. Neurology. 2000. PMID: 10802792

3

Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism.

Makkonen I, Kokki H, Kuikka J, Turpeinen U, Riikonen R. Makkonen I, et al. Among authors: turpeinen u. Neuropediatrics. 2011 Oct;42(5):207-9. doi: 10.1055/s-0031-1291242. Epub 2011 Oct 20. Neuropediatrics. 2011. PMID: 22015434 Clinical Trial.

4

Maternal serum screening for Down's syndrome on population basis.

Salonen R, Turpeinen U, Kurki L, Lappalainen M, Ammälä P, Hiilesmaa V, Teramo K, von Koskull H, Gahmberg N, Stenman UH. Salonen R, et al. Among authors: turpeinen u. Acta Obstet Gynecol Scand. 1997 Oct;76(9):817-21. doi: 10.3109/00016349709024358. Acta Obstet Gynecol Scand. 1997. PMID: 9351405 Free article.

5

Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with progressive encephalopathy, hypsarrhythmia, and optic atrophy (PEHO) syndrome and cerebellar degeneration.

Riikonen R, Somer M, Turpeinen U. Riikonen R, et al. Among authors: turpeinen u. Epilepsia. 1999 Nov;40(11):1642-8. doi: 10.1111/j.1528-1157.1999.tb02051.x. Epilepsia. 1999. PMID: 10565594 Free article.

6

Insulin-like growth factor-I in cerebrospinal fluid and serum in Rett syndrome.

Vanhala R, Turpeinen U, Riikonen PR. Vanhala R, et al. Among authors: turpeinen u. J Child Neurol. 2000 Dec;15(12):797-802. doi: 10.1177/088307380001501205. J Child Neurol. 2000. PMID: 11198494

7

Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism.

Vanhala R, Turpeinen U, Riikonen R. Vanhala R, et al. Among authors: turpeinen u. Dev Med Child Neurol. 2001 Sep;43(9):614-6. doi: 10.1017/s0012162201001116. Dev Med Child Neurol. 2001. PMID: 11570630 Free article. Clinical Trial.

8

Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.

Pirttilä T, Vanhatalo S, Turpeinen U, Riikonen R. Pirttilä T, et al. Among authors: turpeinen u. Acta Neurol Scand. 2004 May;109(5):337-41. doi: 10.1111/j.1600-0404.2004.00223.x. Acta Neurol Scand. 2004. PMID: 15080860

9

Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-2) in children with acute lymphoblastic leukemia.

Riikonen R, Vettenranta K, Riikonen P, Turpeinen U, Saarinen-Pihkala UM. Riikonen R, et al. Among authors: turpeinen u. Pediatr Blood Cancer. 2004 Aug;43(2):110-4. doi: 10.1002/pbc.20072. Pediatr Blood Cancer. 2004. PMID: 15236275

10

Cerebrospinal fluid insulin-like growth factor 1 is low in acute and chronic white-matter diseases of children.

Riikonen R, Turpeinen U. Riikonen R, et al. Among authors: turpeinen u. J Child Neurol. 2005 Mar;20(3):181-4. doi: 10.1177/08830738050200030201. J Child Neurol. 2005. PMID: 15832605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters